BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35446160)

  • 1. Excluding familial hypocalciuric hypercalcaemia before surgery for primary hyperparathyroidism - a practical evaluation of urinary calcium using a retrospective cohort design.
    McAllister J; Arshad MF; Rab E; Balasubramanian SP
    Ann R Coll Surg Engl; 2022 Nov; 104(9):710-716. PubMed ID: 35446160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best?
    Arshad MF; McAllister J; Merchant A; Rab E; Cook J; Eastell R; Balasubramanian S
    Postgrad Med J; 2021 Sep; 97(1151):577-582. PubMed ID: 32892159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of calcium excretion and calcium/creatinine clearance ratio in the differential diagnosis of familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Bhangu JS; Selberherr A; Brammen L; Scheuba C; Riss P
    Head Neck; 2019 May; 41(5):1372-1378. PubMed ID: 30554440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-FHH: A Risk Equation to Facilitate the Diagnosis of Parathyroid-Related Hypercalcemia.
    Bertocchio JP; Tafflet M; Koumakis E; Maruani G; Vargas-Poussou R; Silve C; Nissen PH; Baron S; Prot-Bertoye C; Courbebaisse M; Souberbielle JC; Rejnmark L; Cormier C; Houillier P
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2534-2542. PubMed ID: 29727008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing pre-operative urinary calcium excretion in primary hyperparathyroidism.
    Kaderli RM; Riss P; Geroldinger A; Selberherr A; Scheuba C; Niederle B
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):97-102. PubMed ID: 28383779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
    BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Think twice: a rare calcium sensing receptor mutation and a new diagnosis of familial hypocalciuric hypercalcaemia.
    Tellam JJ; Abdulrasool G; Ciin LCH
    Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32698162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism.
    Shinall MC; Dahir KM; Broome JT
    Endocr Pract; 2013; 19(4):697-702. PubMed ID: 23425644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypocalciuric hypercalcaemia type 1 caused by a novel heterozygous missense variant in the CaSR gene, p(His41Arg): two case reports.
    Courtney A; Hill A; Smith D; Agha A
    BMC Endocr Disord; 2022 Dec; 22(1):324. PubMed ID: 36536367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
    J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism.
    Riss P; Kammer M; Selberherr A; Bichler C; Kaderli R; Scheuba C; Niederle B
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):196-201. PubMed ID: 26921840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical perspective of parathyroid hormone related hypercalcaemia.
    Han CH; Fry CH; Sharma P; Han TS
    Rev Endocr Metab Disord; 2020 Mar; 21(1):77-88. PubMed ID: 31797261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel CASR variant in a family with familial hypocalciuric hypercalcaemia and primary hyperparathyroidism.
    Sagi SV; Joshi H; Trotman J; Elsey T; Swamy A; Rajkanna J; Bhat NA; Haddadin FJS; Oyibo SO; Park SM
    Endocrinol Diabetes Metab Case Rep; 2020 Sep; 2020():. PubMed ID: 33434173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low urine calcium excretion in African American patients with primary hyperparathyroidism.
    Taha W; Singh N; Flack JM; Abou-Samra AB
    Endocr Pract; 2011; 17(6):867-72. PubMed ID: 21613053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is routine 24-hour urine calcium measurement useful during the evaluation of primary hyperparathyroidism?
    Li SR; McCoy KL; Levitt HE; Kelley ML; Carty SE; Yip L
    Surgery; 2022 Jan; 171(1):17-22. PubMed ID: 34325903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.